KARJA PEART: Open Payments
NPI 1538743141 · TUCKER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,833 in 78 payments from 21 companies in 2025. Trend: 2023 $1,732 · 2024 $2,711 · 2025 $2,833
Food & beverage: $2,726Education: $107
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 9 | $348 |
| PFIZER INC. | 6 | $324 |
| Regeneron Healthcare Solutions, Inc. | 8 | $301 |
| UCB, Inc. | 4 | $270 |
| Novartis Pharmaceuticals Corporation | 7 | $250 |
| ABBVIE INC. | 8 | $248 |
| Organon LLC | 3 | $176 |
| Janssen Biotech, Inc. | 5 | $166 |
| Galderma Laboratories, L.P. | 4 | $153 |
| Incyte Corporation | 8 | $148 |
Products named: Zoryve, DUPIXENT, Bimzelx, RINVOQ, TREMFYA, Rhapsido, NEMLUVIO, OPZELURA.
Industry payments across GA — which companies pay providers there.
